It emerged from a body of protein-engineering work in the late 1980s and early 1990s much of it from the Australian laboratories associated with Francis, Ballard, and Wallace aimed at producing IGF analogs with reduced IGFBP affinity but preserved receptor activity, in order to study the relative contributions of binding-protein interaction versus receptor binding to biological potency
Diabetes, Obesity and Metabolism , 19 (7), 1116-1125
Targeting natural killer cells and natural killer T cells in cancer
Accessed 12/15/2023, Donovan L
Participants received daily injections of either Liraglutide (3mg) or a placebo for 56 weeks
Obesity independently increases cardiovascular mortality, and weight loss of 5 to 10% yields meaningful reductions in cardiovascular disease risk factors